Effects of Short-intensity Modified Constraint-induced Movement Therapy on Hand Function in Stroke Patients.
Hemorrhagic Stroke, Ischemic Stroke, Rehabilitation
About this trial
This is an interventional treatment trial for Hemorrhagic Stroke focused on measuring Hemorrhagic Stroke, Ischemic Stroke, Rehabilitation
Eligibility Criteria
Inclusion Criteria: Patients having the First stroke either ischemic or hemorrhagic (3-24 months after stroke) Patients having Mini-mental status examination score (MMSE) ≤23/30 Patients having Passive range of motion (PROM) includes at least 90 degrees shoulder flexion and abduction, 45degrees shoulder external rotation,- 30 degrees elbow extension, and 45 degrees forearm supination and pronation (from a neutral position). At least 10 degrees active wrist extension, 10 degrees abduction/thumb extension, and 10-degree extension at the level of the metacarpophalangeal and interphalangeal joints between the two toes among the II-III-IV-V fingers (these movements will be repeated starting from a resting position 3 times in 1 minute). Exclusion Criteria: Patients having Subarachnoid hemorrhage. Patients having Motor activity log - the amount of use score ≥2.5 Patients having treatment of upper limb spasticity (e.g., botulinum toxin) in the 3 months prior to the start of the study and/or during its execution.
Sites / Locations
- Riphah International UniversityRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
experimental group
control group
an experimental group receiving short-intensity modified CIMT and conventional therapy
a control group receiving conventional therapy alone.